ask="56.02"
ask_size="100"
average_daily_volume="1108280"
bid="43.85"
bid_size="200"
book_value="3.62"
change="-0.15"
change_from_200_day_moving_average="-2.08"
change_from_50_day_moving_average="1.84"
change_from_52_week_high="-11.25"
change_From_52_week_low="11.72"
change_in_percent="-0.34%"
close="43.90"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.63"
ebitda="-145.92M"
eps_estimate_current_year="-2.25"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-1.30"
ex_dividend_date="N/A"
float_shares="85906000"
high="44.47"
high_52_weeks="55.15"
last_trade_date="2/21/2017"
last_trade_price="43.90"
last_trade_size="36527"
last_trade_time="4:00pm"
low="43.64"
low_52_weeks="32.18"
market_capitalization="3.82B"
moving_average_200_day="45.98"
moving_average_50_day="42.06"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="67.67"
open="44.18"
pe_ratio="N/A"
peg_ratio="0.54"
percent_change_from_200_day_moving_average="-4.52%"
percent_change_from_50_day_moving_average="+4.37%"
percent_change_from_52_week_high="-20.40%"
percent_change_from_52_week_low="+36.42%"
previous_close="44.05"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="12.16"
price_per_sales="255.82"
revenue="15.00M"
shares_outstanding="87114000"
short_ratio="3.01"
stock_exchange="NMS"
symbol="NBIX"
volume="772984"
weeks_range_52="32.18 - 55.15"
